Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mereckiene, J."" wg kryterium: Autor


Tytuł :
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.
Autorzy :
Bennett JC; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Hetrich MK; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Garcia Quesada M; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Sinkevitch JN; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Deloria Knoll M; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Feikin DR; Independent Consultant, 1296 Coppet, Switzerland.
Zeger SL; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Kagucia EW; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya.
Cohen AL; World Health Organization, 1202 Geneva, Switzerland.
Ampofo K; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA.
Brandileone MC; National Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil.
Bruden D; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA.
Camilli R; Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy.
Castilla J; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Instituto de Salud Pública de Navarra-IdiSNA, 31003 Pamplona, Navarra, Spain.
Chan G; Singapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore.
Cook H; Centre for Disease Control, Department of Health and Community Services, Darwin, NT 8000, Australia.
Cornick JE; Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool CH64 7TE, UK.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre 3, Malawi.
Dagan R; Faculty of Health Sciences, Ben-Gurion University of the Negev, 8410501 Beer-Sheva, Israel.
Dalby T; Bacteria, Parasites and Fungi, Statens Serum Institut, DK-2300 Copenhagen, Denmark.
Danis K; Santé Publique France, the French National Public Health Agency, Saint Maurice CEDEX, 94415 Paris, France.
de Miguel S; Epidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain.
De Wals P; Department of Social and Preventive Medicine, Laval University, Québec, QC G1V 0A6, Canada.
Desmet S; Department of Microbiology, Immunology and Transplantation, KU Leuven, BE-3000 Leuven, Belgium.; National Reference Centre for Streptococcus Pneumoniae, University Hospitals Leuven, 3000 Leuven, Belgium.
Georgakopoulou T; National Public Health Organisation, 15123 Athens, Greece.
Gilkison C; Epidemiology Team, Institute of Environmental Science and Research, Porirua, 5240 Wellington, New Zealand.
Grgic-Vitek M; Communicable Diseases Centre, National Institute of Public Health, 1000 Ljubljana, Slovenia.
Hammitt LL; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya.
Hilty M; Swiss National Reference Centre for Invasive Pneumococci, Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland.
Ho PL; Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China.
Jayasinghe S; National Centre for Immunisation Research and Surveillance and Discipline of Child and Adolescent Health, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia.
Kellner JD; Department of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada.
Kleynhans J; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 2000 Johannesburg, South Africa.
Knol MJ; National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands.
Kozakova J; National Institute of Public Health (NIPH), 100 42, Praha Czech Republic.
Kristinsson KG; Department of Clinical Microbiology, Landspitali-The National University Hospital, Hringbraut, 101 Reykjavik, Iceland.
Ladhani SN; Immunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK.
MacDonald L; Public Health Scotland, Glasgow G2 6QE, UK.
Mackenzie GA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St, London, WC1E 7HT, UK.; Medical Research Council Unit the Gambia atLondon School of Hygiene & Tropical Medicine, P.O. Box 273, Banjul, The Gambia.; New Vaccines Group, Murdoch Children's Research Institute, Parkville, Melbourne, 3052, Victoria, Australia.
Mad'arová L; National Reference Centre for Pneumococcal and Haemophilus Diseases, Regional Authority of Public Health, 975 56 Banská Bystrica, Slovakia.
McGeer A; Toronto Invasive Bacterial Diseases Network, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Mereckiene J; HSE Health Protection Surveillance Centre, Mountjoy, Dublin D01 A4A3, Ireland.
Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden.
Mungun T; National Center of Communicable Diseases (NCCD), Ministry of Health, Bayanzurkh District, Ulaanbaatar 13336, Mongolia.
Muñoz-Almagro C; CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain.; Medicine Department, Universitat Internacional de Catalunya, 08017 Barcelona, Spain.; Molecular Microbiology Department, Hospital Sant Joan de Déu Research Institute, 08950 Esplugues de Llobregat, Barcelona, Spain.
Nuorti JP; Department of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.; Health Sciences Unit, Faculty of Social Sciences, University of Tampere, 33100 Tampere, Finland.
Paragi M; Centre for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia.
Pilishvili T; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Puentes R; Instituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile.
Saha SK; Child Health Research Foundation, Dhaka 1207, Bangladesh.
Sahu Khan A; Ministry of Health and Medical Services, Suva, Fiji.
Savrasova L; Centre for Disease Prevention and Control of Latvia, 1005 Riga, Latvia.; Doctoral Studies Department, Riga Stradinš University, 1007 Riga, Latvia.
Scott JA; KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya.
Skoczyńska A; National Reference Centre for Bacterial Meningitis, National Medicines Institute, 00-725 Warsaw, Poland.
Suga S; Infectious Disease Center and Department of Clinical Research, National Hospital Organization Mie Hospital, Tsu, Mie 514-0125, Japan.
van der Linden M; National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany.
Verani JR; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.; Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global Health Protection (DGHP), Nairobi, Kenya.
von Gottberg A; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa.; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg 2000, South Africa.
Winje BA; Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway.
Yildirim I; Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, CT 06504, USA.
Zerouali K; Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco.; Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 20000, Morocco.
Hayford K; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
The Pserenade Team
Pokaż więcej
Źródło :
Microorganisms [Microorganisms] 2021 Mar 27; Vol. 9 (4). Date of Electronic Publication: 2021 Mar 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018.
Autorzy :
Corcoran M; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Murchan S; Health Protection Surveillance Centre, Dublin, Ireland.
Cunney R; From the Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland.; Department of Microbiology, Children's Health Ireland at Temple Street, Dublin, Ireland.
Humphreys H; Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, Dublin, Ireland.; Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
Pokaż więcej
Źródło :
The Pediatric infectious disease journal [Pediatr Infect Dis J] 2020 Apr; Vol. 39 (4), pp. 339-344.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Heptavalent Pneumococcal Conjugate Vaccine/*administration & dosage
Pneumococcal Infections/*epidemiology
Pneumococcal Vaccines/*administration & dosage
Adolescent ; Child ; Child, Preschool ; Humans ; Immunization Schedule ; Incidence ; Infant ; Ireland/epidemiology ; Pneumococcal Infections/etiology ; Pneumococcal Infections/prevention & control ; Serogroup ; Streptococcus pneumoniae/classification ; Streptococcus pneumoniae/isolation & purification ; Treatment Failure
Czasopismo naukowe
Tytuł :
Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season.
Autorzy :
Quattrocchi A; Health Protection Surveillance Centre, Dublin, Ireland; European Programme for Intervention Epidemiology Training, Stockholm, Sweden.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: jolita.mereckiene@hse.ie.
Fitzgerald M; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2019 Oct 08; Vol. 37 (43), pp. 6390-6396. Date of Electronic Publication: 2019 Sep 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Influenza Vaccines/*administration & dosage
Patient Acceptance of Health Care/*statistics & numerical data
Pertussis Vaccine/*administration & dosage
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Cross-Sectional Studies ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Influenza Vaccines/immunology ; Influenza, Human/prevention & control ; Ireland/epidemiology ; Middle Aged ; Pertussis Vaccine/immunology ; Pregnancy ; Pregnancy Complications, Infectious/prevention & control ; Pregnant Women ; Surveys and Questionnaires ; Whooping Cough/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
Autorzy :
Hanquet G; EpiConcept, Paris, France.; Antwerp University, Antwerp, Belgium.
Krizova P; National Institute of Public Health, Prague, Czech Republic.
Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark.
Ladhani SN; Public Health England, London, UK.
Nuorti JP; National Institute for Health and Welfare, Helsinki, Finland.; University of Tampere, Tampere, Finland.
Lepoutre A; Santé publique France, Saint-Maurice, France.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Knol M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Winje BA; Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; Public Health Agency of Catalunya, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; General Directorate of Public Health, Madrid, Spain.
Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; National Institute of Public Health, Prague, Czech Republic.
Slotved HC; Statens Serum Institut, Copenhagen, Denmark.
Fry NK; Public Health England, London, UK.
Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Corcoran M; Irish Pneumococcal Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.
van der Ende A; Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The Netherlands.
Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Recerca Pediátrica, Hospital Sant Joan de Deu, Universitat Internacional de Catalunya, Barcelona, Spain.
Latasa P; General Directorate of Public Health, Madrid, Spain.
Castilla J; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Public Health Agency of Sweden, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Whittaker R; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Savulescu C; EpiConcept, Paris, France.
Pokaż więcej
Corporate Authors :
SpIDnet/I-MOVE+ Pneumo Group
Źródło :
Thorax [Thorax] 2019 May; Vol. 74 (5), pp. 473-482. Date of Electronic Publication: 2018 Oct 24.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumococcal Vaccines/*pharmacology
Streptococcus pneumoniae/*immunology
Vaccination/*methods
Aged ; Europe/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Retrospective Studies ; Serogroup
Czasopismo naukowe
Tytuł :
Is It Time To Review The Vaccination Strategy To Protect Adults Against Invasive Pneumococcal Disease?
Autorzy :
Corcoran M; The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland.
Murchan S; Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland.
McElligott M; The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland.; Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, RCSI Education & Research Centre, Beaumont Hospital, Beaumont, Dublin 9, Ireland.
’Flanagan D; Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland.
Cotter S; Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland.
Cunney R; The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland.; Health Protection Surveillance Centre, Dublin, Gardiner Street, Dublin 1, Ireland.; Department of Microbiology, Temple Street Children’s University Hospital, Dublin 1, Ireland.
Humphreys H; The Irish Pneumococcal Reference Laboratory, Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children’s University Hospital, Temple Street, Dublin 1, Ireland.; Department of Clinical Microbiology, the Royal College of Surgeons in Ireland, RCSI Education & Research Centre, Beaumont Hospital, Beaumont, Dublin 9, Ireland.; Department of Microbiology, Beaumont Hospital, Beaumont, Dublin 9, Ireland.
Pokaż więcej
Źródło :
Irish medical journal [Ir Med J] 2019 Mar 14; Vol. 112 (3), pp. 894. Date of Electronic Publication: 2019 Mar 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumococcal Vaccines*/administration & dosage
Serogroup*
Vaccines, Conjugate*/administration & dosage
Pneumococcal Infections/*microbiology
Pneumococcal Infections/*prevention & control
Streptococcus pneumoniae/*classification
Streptococcus pneumoniae/*isolation & purification
Aged ; Aged, 80 and over ; Cost of Illness ; Female ; Humans ; Incidence ; Ireland/epidemiology ; Male ; Pneumococcal Infections/epidemiology
Czasopismo naukowe
Tytuł :
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
Autorzy :
Jorgensen P; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark. Electronic address: .
Mereckiene J; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Cotter S; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Johansen K; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Tsolova S; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Brown C; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Jan 25; Vol. 36 (4), pp. 442-452. Date of Electronic Publication: 2017 Dec 26.
Typ publikacji :
Historical Article; Journal Article
MeSH Terms :
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/immunology
Vaccination*
Vaccination Coverage*
Influenza, Human/*epidemiology
Influenza, Human/*prevention & control
Age Factors ; Europe/epidemiology ; European Union ; Female ; Geography, Medical ; Health Personnel ; Health Policy ; History, 21st Century ; Humans ; Immunization Programs ; Influenza, Human/history ; Male ; Population Surveillance ; Pregnancy ; Public Health Surveillance ; Seasons ; World Health Organization
Czasopismo naukowe
Tytuł :
Decrease in the Uptake of Seasonal Influenza Vaccine in Persons Aged 65 Years and Older In Ireland since the 2009 Influenza A (H1N1) Pdm09 Pandemic.
Autorzy :
Chaintarli K; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Solna, Sweden.; Health Protection Surveillance Centre, Dublin, Ireland.
Barrassa A; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Solna, Sweden.; Institute of Health Carlos III, Spain.
Cotter S; Health Protection Surveillance Centre, Dublin, Ireland.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
O'Donnell J; Health Protection Surveillance Centre, Dublin, Ireland.
Domegan L; Health Protection Surveillance Centre, Dublin, Ireland.
Pokaż więcej
Źródło :
Irish medical journal [Ir Med J] 2017 Oct 10; Vol. 110 (9), pp. 630. Date of Electronic Publication: 2017 Oct 10.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza A Virus, H1N1 Subtype*
Influenza, Human*/epidemiology
Influenza, Human*/prevention & control
Influenza Vaccines/*administration & dosage
Vaccination/*statistics & numerical data
Age Factors ; Aged ; General Practice/statistics & numerical data ; Humans ; Ireland/epidemiology ; Pandemics ; Poisson Distribution ; Poverty Areas ; Seasons ; Vaccination/trends
Czasopismo naukowe
Tytuł :
The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?
Autorzy :
Corcoran M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Vickers I; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Mereckiene J; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Murchan S; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Cotter S; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Fitzgerald M; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
McElligott M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Cafferkey M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
O'Flanagan D; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Cunney R; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Humphreys H; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Pokaż więcej
Źródło :
Epidemiology and infection [Epidemiol Infect] 2017 Aug; Vol. 145 (11), pp. 2390-2399.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Streptococcus pneumoniae/*immunology
Aged ; Aged, 80 and over ; Humans ; Ireland/epidemiology ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/microbiology
Czasopismo naukowe
Tytuł :
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
Autorzy :
Savulescu C; Epidemiology Department, EpiConcept, Paris, France. Electronic address: .
Krizova P; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Lepoutre A; Infectious Disease Department, French National Agency for Public Health, Saint-Maurice, France.
Mereckiene J; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; General Sub-Directorate for Surveillance and Public Health Emergency Response, Public Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Guevara M; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Cotter S; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Winje BA; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain; Molecular Microbiology Department, Hospital Sant Joan de Déu, Barcelona, Spain; International University of Catalunya, Barcelona, Spain.
Garcia L; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Castilla J; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Celentano LP; Office of Chief Scientist Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hanquet G; Epidemiology Department, EpiConcept, Paris, France.
Pokaż więcej
Corporate Authors :
SpIDnet group
Źródło :
The Lancet. Respiratory medicine [Lancet Respir Med] 2017 Aug; Vol. 5 (8), pp. 648-656. Date of Electronic Publication: 2017 Mar 27.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Immunization Programs/*statistics & numerical data
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*therapeutic use
Child, Preschool ; Europe/epidemiology ; Female ; Humans ; Incidence ; Infant ; Male ; Outcome Assessment, Health Care ; Streptococcus pneumoniae/immunology
Czasopismo naukowe
Tytuł :
Tuberculosis contact investigations associated with air travel in Ireland, September 2011 to November 2014.
Autorzy :
Flanagan P; Health Protection Surveillance Centre, Dublin, Ireland.
O'Donnell J
Mereckiene J
O'Flanagan D
Pokaż więcej
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2016 Oct 06; Vol. 21 (40).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Air Travel*
Aircraft*
Contact Tracing/*statistics & numerical data
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis, Pulmonary/*diagnosis
Adult ; Contact Tracing/methods ; Disease Notification ; Female ; Humans ; Ireland ; Male ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Factors ; Sputum/microbiology ; Tuberculin Test ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/transmission
Czasopismo naukowe
Tytuł :
Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
Autorzy :
Giese C; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Mereckiene J; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Danis K; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
O'Donnell J; HSE Health Protection Surveillance Centre, Dublin, Ireland.
O'Flanagan D; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; HSE Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2016 Jul 12; Vol. 34 (32), pp. 3657-62. Date of Electronic Publication: 2016 Jun 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Personnel*
Vulnerable Populations*
Influenza Vaccines/*therapeutic use
Pneumococcal Vaccines/*therapeutic use
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Aged ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Influenza, Human/prevention & control ; Ireland ; Male ; Middle Aged ; Pneumococcal Infections/prevention & control ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Tytuł :
Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
Autorzy :
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S
Nicoll A
Lopalco P
Noori T
Weber J
D'Ancona F
Levy-Bruhl D
Dematte L
Giambi C
Valentiner-Branth P
Stankiewicz I
Appelgren E
O Flanagan D
Pokaż więcej
Corporate Authors :
VENICE project gatekeepers group
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2014 Apr 24; Vol. 19 (16), pp. 20780. Date of Electronic Publication: 2014 Apr 24.
Typ publikacji :
Journal Article
MeSH Terms :
Pandemics*
Seasons*
Immunization Programs/*statistics & numerical data
Influenza, Human/*prevention & control
Vaccination/*statistics & numerical data
Adult ; Aged ; Europe/epidemiology ; Female ; Health Care Surveys ; Health Planning Guidelines ; Humans ; Influenza A Virus, H1N1 Subtype/isolation & purification ; Influenza, Human/epidemiology ; Male ; Pilot Projects ; Risk Factors ; Surveys and Questionnaires ; Vulnerable Populations
Czasopismo naukowe
Tytuł :
Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).
Autorzy :
Mereckiene, J.
Cotter, S.
Nicoll, A.
Lopalco, P.
Noori, T.
Weber, J. T.
D'Ancona, F.
Lévy-Bruhl, D.
Dematte, L.
Giambi, C.
Valentiner-Branth, P.
Stankiewicz, I.
Appelgren, E.
O'Flanagan, D.
Pokaż więcej
Źródło :
Eurosurveillance (15607917); 4/24/2014, Vol. 19 Issue 16, p29-39, 11p, 4 Charts, 2 Graphs
Czasopismo naukowe
Tytuł :
Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.
Autorzy :
Jorgensen P; World Health Organization Regional Office for Europe, Copenhagen, Denmark. />Wasley A
Mereckiene J
Cotter S
Weber JT
Brown CS
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2013 Aug 28; Vol. 31 (38), pp. 4060-2. Date of Electronic Publication: 2013 Jul 08.
Typ publikacji :
Journal Article
MeSH Terms :
Influenza Vaccines*
Healthcare Disparities/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*pathogenicity
Influenza, Human/*epidemiology
Vaccination/*statistics & numerical data
Data Collection ; Europe/epidemiology ; Humans ; Immunization Programs/organization & administration ; Influenza, Human/virology
Czasopismo naukowe
Tytuł :
Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage.
Autorzy :
Kanitz EE; National Centre for Epidemiology, Surveillance and Health Promotion-CNESPS, Istituto Superiore di Sanità, Rome, Italy.
Wu LA
Giambi C
Strikas RA
Levy-Bruhl D
Stefanoff P
Mereckiene J
Appelgren E
D'Ancona F
Pokaż więcej
Corporate Authors :
VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points
Źródło :
Vaccine [Vaccine] 2012 Jul 27; Vol. 30 (35), pp. 5222-8. Date of Electronic Publication: 2012 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
Health Policy*
Immunization Programs/*statistics & numerical data
Vaccines/*administration & dosage
Adult ; European Union ; Humans ; Iceland ; Immunization Programs/methods ; Norway ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.
Autorzy :
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland. jolita.mereckiene@hse.ie
Cotter S
Weber JT
Nicoll A
D'Ancona F
Lopalco PL
Johansen K
Wasley AM
Jorgensen P
Lévy-Bruhl D
Giambi C
Stefanoff P
Dematte L
O'Flanagan D
Pokaż więcej
Corporate Authors :
VENICE project gatekeepers group
Źródło :
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2012 Jan 26; Vol. 17 (4). Date of Electronic Publication: 2012 Jan 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Policy*/economics
Influenza A Virus, H1N1 Subtype*
Influenza, Human/*prevention & control
Universal Health Insurance/*standards
Vaccination/*standards
Europe/epidemiology ; Health Surveys/methods ; Humans ; Iceland/epidemiology ; Influenza, Human/epidemiology ; Norway/epidemiology ; Pandemics/economics ; Universal Health Insurance/economics ; Vaccination/economics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies